Vaquez's disease

disorder

SNOMED 109992005CUI C0032461

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Uramustine

substance

Pipobroman

substance

Anagrelide hydrochloride

substance

Anagrelide

substance

Interferon alfa-2b

substance

Busulphan

substance

Hydroxyurea

substance

Ruxolitinib

substance

Ruxolitinib phosphate

substance

Ropeginterferon alfa-2b

substance

Clinical Trials

Total Trials

Recruiting

With Results

Recent Trials

CPAP Effect on the Polycythemia in Patients With Obstructive Sleep Apnea

NCT06089603Phase 4Recruiting182 enrolled

Treatment of High Altitude Polycythemia by Acetazolamide

NCT00424970Phase 4Completed55 enrolled

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

NCT01558739Phase 4Completed48 enrolled

View all 3 trials on ClinicalTrials.gov

Research Evidence

Peer-reviewed studies linked via MeSH term "Polycythemia" from the MEDLINE/PubMed database.

Sort:

Diagnosis, management, and outcomes of drug-induced erythrocytosis: a systematic review.

[object Object], [object Object], [object Object] et al. · Blood Adv · 2025

PMID: 39913688Meta-AnalysisFull text (PMC)

Effect of testosterone formulations on hematocrit in transgender individuals: A systematic review.

[object Object], [object Object], [object Object] et al. · Andrology · 2025

PMID: 39011565Meta-Analysis

Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review.

[object Object], [object Object], [object Object] et al. · Minerva Endocrinol (Torino) · 2024

PMID: 39028210Meta-Analysis

Mountain sickness in altitude inhabitants of Latin America: A systematic review and meta-analysis.

[object Object], [object Object], [object Object] et al. · PLoS One · 2024

PMID: 39316567Meta-AnalysisFull text (PMC)

JAK2-V617F mutation among blood donors: A meta-analysis.

[object Object], [object Object], [object Object] et al. · Saudi Med J · 2024

PMID: 39658117Meta-AnalysisFull text (PMC)

The utility of testing erythropoietin level in polycythemia diagnosis.

[object Object], [object Object], [object Object] et al. · Hematology · 2023

PMID: 37843428Meta-Analysis

Selective intrauterine growth restriction without concomitant twin-to-twin transfusion syndrome, natural history, and risk factors for fetal death: A systematic review and meta-analysis.

[object Object], [object Object], [object Object] et al. · Am J Obstet Gynecol MFM · 2023

PMID: 37527736Meta-Analysis

Prevalence of elevated hemoglobin and hematocrit levels in patients with obstructive sleep apnea and the impact of treatment with continuous positive airway pressure: a meta-analysis.

[object Object], [object Object], [object Object] et al. · Hematology · 2022

PMID: 35962574Meta-Analysis

Solomon technique vs selective fetoscopic laser photocoagulation for twin-twin transfusion syndrome: systematic review and meta-analysis of maternal and perinatal outcomes.

[object Object], [object Object], [object Object] et al. · Ultrasound Obstet Gynecol · 2022

PMID: 36240516Meta-Analysis

Controversies in Testosterone Therapy.

[object Object], [object Object], [object Object] · Sex Med Rev · 2021

PMID: 33309270Meta-Analysis

Search all PubMed articles for Vaquez's disease

Research data from MEDLINE/PubMed

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Abdominal discomfort

Very frequent (80-99%)HP:0002027

Acute leukemias

Very frequent (80-99%)HP:0002488

Angina pectoris

Very frequent (80-99%)HP:0001681

Bleeding gums

Very frequent (80-99%)HP:0000225

Bruising susceptibility

Very frequent (80-99%)HP:0000978

Enlarged liver

Very frequent (80-99%)HP:0002240

Erythrocytosis

Very frequent (80-99%)HP:0001901

Headache

Very frequent (80-99%)HP:0002315

High blood pressure

Very frequent (80-99%)HP:0000822

Large spleen

Very frequent (80-99%)HP:0001744

Myelodysplasia

Very frequent (80-99%)HP:0002863

Myelofibrosis

Very frequent (80-99%)HP:0011974

Nasal hemorrhage

Very frequent (80-99%)HP:0000421

Ringing in ears

Very frequent (80-99%)HP:0000360

Vertigo

Very frequent (80-99%)HP:0002321

Weight loss

Very frequent (80-99%)HP:0001824

Abnormality of vision

Frequent (30-79%)HP:0000504

Arthritic pain

Frequent (30-79%)HP:0002829

Paresthesia

Frequent (30-79%)HP:0003401

Respiratory function loss

Frequent (30-79%)HP:0002093

Tiredness

Frequent (30-79%)HP:0012378

Blood clot in artery

Occasional (5-29%)HP:0004420

Blood clot in artery of lung

Occasional (5-29%)HP:0002204

Blood clot in vein

Occasional (5-29%)HP:0004936

Budd-Chiari syndrome

Occasional (5-29%)HP:0002639

Cerebral vascular events

Occasional (5-29%)HP:0001297

Erythromelalgia

Occasional (5-29%)HP:0032147

Feeling full quickly when eating

Occasional (5-29%)HP:0033842

Gastrointestinal haemorrhage

Occasional (5-29%)HP:0002239

Increased total leukocyte count

Occasional (5-29%)HP:0001974

Related Conditions

Familial polycythemia vera(child)

Polycythaemia vera in remission(child)

Chronic myeloproliferative disorder (clinical)(parent)

Quick Facts

SNOMED CT: 109992005
UMLS CUI: C0032461
Fully Specified Name: Polycythemia vera (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 30
Known Treatments: 10
Clinical Trials: 3

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.